These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

804 related articles for article (PubMed ID: 28487465)

  • 1. Geriatric Assessment Predicts Survival and Competing Mortality in Elderly Patients with Early Colorectal Cancer: Can It Help in Adjuvant Therapy Decision-Making?
    Antonio M; Saldaña J; Carmona-Bayonas A; Navarro V; Tebé C; Nadal M; Formiga F; Salazar R; Borràs JM
    Oncologist; 2017 Aug; 22(8):934-943. PubMed ID: 28487465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predicting Adherence to a Tailored-Dose Adjuvant Treatment on the Basis of Geriatric Assessment in Elderly People With Colorectal Cancer: A Prospective Study.
    Antonio M; Carmona-Bayonas A; Saldaña J; Navarro V; Tebé C; Salazar R; Borràs JM
    Clin Colorectal Cancer; 2018 Mar; 17(1):e59-e68. PubMed ID: 29054805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for colorectal cancer in the elderly.
    Kim JH
    World J Gastroenterol; 2015 May; 21(17):5158-66. PubMed ID: 25954089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity Outcomes in a Population-based Cohort of Elderly Patients Treated With Adjuvant Oxaliplatin for Colorectal Cancer.
    Raphael MJ; Fischer HD; Fung K; Austin PC; Anderson GM; Booth CM; Singh S
    Clin Colorectal Cancer; 2017 Dec; 16(4):397-404.e1. PubMed ID: 28434884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer.
    Antonio M; Saldaña J; Linares J; Ruffinelli JC; Palmero R; Navarro A; Arnaiz MD; Brao I; Aso S; Padrones S; Navarro V; González-Barboteo J; Borràs JM; Cardenal F; Nadal E
    Br J Cancer; 2018 Mar; 118(5):639-647. PubMed ID: 29381689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.
    Barthélémy P; Heitz D; Mathelin C; Polesi H; Asmane I; Litique V; Rob L; Bergerat JP; Kurtz JE
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):196-204. PubMed ID: 20655243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
    Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
    Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in the elderly: is palliative chemotherapy of value?
    Honecker F; Köhne CH; Bokemeyer C
    Drugs Aging; 2003; 20(1):1-11. PubMed ID: 12513112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early breast cancer in the elderly: assessment and management considerations.
    Albrand G; Terret C
    Drugs Aging; 2008; 25(1):35-45. PubMed ID: 18184027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
    Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
    Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.
    Yamano T; Yamauchi S; Kimura K; Babaya A; Hamanaka M; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Tomita N; Sugihara K;
    Eur J Cancer; 2017 Aug; 81():90-101. PubMed ID: 28622612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in elderly patients with breast cancer: key challenges.
    Pondé N; Dal Lago L; Azim HA
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):661-71. PubMed ID: 27010772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frailty status but not age predicts complications in elderly cancer patients: a follow-up study.
    Ørum M; Gregersen M; Jensen K; Meldgaard P; Damsgaard EMS
    Acta Oncol; 2018 Nov; 57(11):1458-1466. PubMed ID: 30280625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study.
    Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M
    Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
    Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.
    Lemmens VE; van Halteren AH; Janssen-Heijnen ML; Vreugdenhil G; Repelaer van Driel OJ; Coebergh JW
    Ann Oncol; 2005 May; 16(5):767-72. PubMed ID: 15817594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of survival from colorectal cancer in Denmark.
    Iversen LH
    Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.
    He Y; Liu P; Zhang Y; Deng X; Meng W; Wei M; Yang T; Wang Z; Qiu M
    Trials; 2015 May; 16():238. PubMed ID: 26021722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.